foxo4-dri senolytic FOX04 FOXO4-DRI Vial 10mg — Stemcode
FOXO4 DRI Vial 10mg Stemcode Peptides FOX04 DRI FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10




